eFT226
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for eFT226, covering 2024-05-21 to 2024-05-21. Get the full timeline:
Most recent: Clinical Trial Update: Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies [Phase 1, Phase 2]